1. Home
  2. USNA vs CCAP Comparison

USNA vs CCAP Comparison

Compare USNA & CCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USNA
  • CCAP
  • Stock Information
  • Founded
  • USNA 1992
  • CCAP 2015
  • Country
  • USNA United States
  • CCAP United States
  • Employees
  • USNA N/A
  • CCAP N/A
  • Industry
  • USNA Medicinal Chemicals and Botanical Products
  • CCAP Finance: Consumer Services
  • Sector
  • USNA Health Care
  • CCAP Finance
  • Exchange
  • USNA Nasdaq
  • CCAP Nasdaq
  • Market Cap
  • USNA 565.5M
  • CCAP 562.2M
  • IPO Year
  • USNA 1996
  • CCAP N/A
  • Fundamental
  • Price
  • USNA $26.46
  • CCAP $13.94
  • Analyst Decision
  • USNA Hold
  • CCAP Buy
  • Analyst Count
  • USNA 1
  • CCAP 4
  • Target Price
  • USNA $36.00
  • CCAP $16.38
  • AVG Volume (30 Days)
  • USNA 136.2K
  • CCAP 198.7K
  • Earning Date
  • USNA 10-21-2025
  • CCAP 11-10-2025
  • Dividend Yield
  • USNA N/A
  • CCAP 13.11%
  • EPS Growth
  • USNA N/A
  • CCAP N/A
  • EPS
  • USNA 1.80
  • CCAP 1.19
  • Revenue
  • USNA $899,221,000.00
  • CCAP $183,172,000.00
  • Revenue This Year
  • USNA $13.94
  • CCAP N/A
  • Revenue Next Year
  • USNA $7.95
  • CCAP $1.65
  • P/E Ratio
  • USNA $14.84
  • CCAP $11.89
  • Revenue Growth
  • USNA 2.75
  • CCAP N/A
  • 52 Week Low
  • USNA $23.10
  • CCAP $13.54
  • 52 Week High
  • USNA $41.84
  • CCAP $20.19
  • Technical
  • Relative Strength Index (RSI)
  • USNA 27.82
  • CCAP 23.22
  • Support Level
  • USNA $26.88
  • CCAP $13.95
  • Resistance Level
  • USNA $27.95
  • CCAP $14.41
  • Average True Range (ATR)
  • USNA 0.74
  • CCAP 0.30
  • MACD
  • USNA -0.27
  • CCAP -0.17
  • Stochastic Oscillator
  • USNA 3.47
  • CCAP 8.12

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About CCAP Crescent Capital BDC Inc. Common stock

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.

Share on Social Networks: